These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 28838644

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Advantages of laparoscopic resection for ileocecal Crohn's disease.
    Duepree HJ, Senagore AJ, Delaney CP, Brady KM, Fazio VW.
    Dis Colon Rectum; 2002 May; 45(5):605-10. PubMed ID: 12004208
    [Abstract] [Full Text] [Related]

  • 44. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM, Perry CM.
    BioDrugs; 2002 May; 16(2):111-48. PubMed ID: 11985485
    [Abstract] [Full Text] [Related]

  • 45. Laparoscopic ileocecal resection in Crohn's disease: a case-matched comparison with open resection.
    Benoist S, Panis Y, Beaufour A, Bouhnik Y, Matuchansky C, Valleur P.
    Surg Endosc; 2003 May; 17(5):814-8. PubMed ID: 12584603
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Longer small bowel segments are resected in emergency surgery for ileocaecal Crohn's disease with a higher ileostomy and complication rate.
    Celentano V, O'Leary DP, Caiazzo A, Flashman KG, Sagias F, Conti J, Senapati A, Khan J.
    Tech Coloproctol; 2019 Nov; 23(11):1085-1091. PubMed ID: 31664551
    [Abstract] [Full Text] [Related]

  • 50. Single-incision laparoscopic surgery for ileocolic resection in Crohn's disease.
    Rijcken E, Mennigen R, Argyris I, Senninger N, Bruewer M.
    Dis Colon Rectum; 2012 Feb; 55(2):140-6. PubMed ID: 22228156
    [Abstract] [Full Text] [Related]

  • 51. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial.
    Jongsma MME, Aardoom MA, Cozijnsen MA, van Pieterson M, de Meij T, Groeneweg M, Norbruis OF, Wolters VM, van Wering HM, Hojsak I, Kolho KL, Hummel T, Stapelbroek J, van der Feen C, van Rheenen PF, van Wijk MP, Teklenburg-Roord STA, Schreurs MWJ, Rizopoulos D, Doukas M, Escher JC, Samsom JN, de Ridder L.
    Gut; 2022 Jan; 71(1):34-42. PubMed ID: 33384335
    [Abstract] [Full Text] [Related]

  • 52. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G, Siproudhis L, Gizard E, Wallenhorst T, Billioud V, Bretagne JF, Bigard MA, Peyrin-Biroulet L.
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [Abstract] [Full Text] [Related]

  • 53. Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
    Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, Plevy S, Popp J, Cornillie FJ, Lukas M, Danese S, Gionchetti P, Hanauer SB, Reinisch W, Sandborn WJ, Sorrentino D, Rutgeerts P, PREVENT Study Group.
    Gastroenterology; 2016 Jun; 150(7):1568-1578. PubMed ID: 26946343
    [Abstract] [Full Text] [Related]

  • 54. Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.
    de Groof EJ, Buskens CJ, Ponsioen CY, Dijkgraaf MG, D'Haens GR, Srivastava N, van Acker GJ, Jansen JM, Gerhards MF, Dijkstra G, Lange JF, Witteman BJ, Kruyt PM, Pronk A, van Tuyl SA, Bodelier A, Crolla RM, West RL, Vrijland WW, Consten EC, Brink MA, Tuynman JB, de Boer NK, Breukink SO, Pierik MJ, Oldenburg B, van der Meulen AE, Bonsing BA, Spinelli A, Danese S, Sacchi M, Warusavitarne J, Hart A, Yassin NA, Kennelly RP, Cullen GJ, Winter DC, Hawthorne AB, Torkington J, Bemelman WA.
    Trials; 2015 Aug 20; 16():366. PubMed ID: 26289163
    [Abstract] [Full Text] [Related]

  • 55. Prospective assessment of the effect on quality of life of anti-tumour necrosis factor therapy for perineal Crohn's fistulas.
    Ng SC, Plamondon S, Gupta A, Burling D, Kamm MA.
    Aliment Pharmacol Ther; 2009 Oct 20; 30(7):757-66. PubMed ID: 19575762
    [Abstract] [Full Text] [Related]

  • 56. Long-term surgical recurrence, morbidity, quality of life, and body image of laparoscopic-assisted vs. open ileocolic resection for Crohn's disease: a comparative study.
    Eshuis EJ, Polle SW, Slors JF, Hommes DW, Sprangers MA, Gouma DJ, Bemelman WA.
    Dis Colon Rectum; 2008 Jun 20; 51(6):858-67. PubMed ID: 18266036
    [Abstract] [Full Text] [Related]

  • 57. Laparoscopic ileocecectomy in pediatric patients with Crohn's disease.
    Laituri CA, Fraser JD, Garey CL, Aguayo P, Sharp SW, Ostlie DJ, Holcomb GW, St Peter SD.
    J Laparoendosc Adv Surg Tech A; 2011 Mar 20; 21(2):193-5. PubMed ID: 21401410
    [Abstract] [Full Text] [Related]

  • 58. Fecal calprotectin one year after ileocaecal resection for Crohn's disease--a comparison with findings at ileocolonoscopy.
    Lasson A, Strid H, Ohman L, Isaksson S, Olsson M, Rydström B, Ung KA, Stotzer PO.
    J Crohns Colitis; 2014 Aug 20; 8(8):789-95. PubMed ID: 24418661
    [Abstract] [Full Text] [Related]

  • 59. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
    Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P, ACCENT I Study Group.
    Lancet; 2002 May 04; 359(9317):1541-9. PubMed ID: 12047962
    [Abstract] [Full Text] [Related]

  • 60. Laparoscopic-assisted ileocecal resection for Crohn's disease: a preliminary study.
    Jess P, Moller EH, Ladefoged K, Christiansen J.
    Scand J Gastroenterol; 1996 Mar 04; 31(3):302-4. PubMed ID: 8833362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.